Insulin glargine-aglr
Insulin glargine-aglr is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand names including Rezvoglar KwikPen, REZVOGLAR KWIKPEN. Available dosage form: injection, solution.
Drug details
- Generic Name
- Insulin glargine-aglr
- Brand Names
- Rezvoglar KwikPen, REZVOGLAR KWIKPEN
- Application Number
- BLA761215
- Sponsor
- Eli Lilly And Company
- NDC Codes
- 2
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- INSULIN GLARGINE
Indications and Usage
1 INDICATIONS AND USAGE REZVOGLAR™ is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. Limitations of Use REZVOGLAR is not recommended for the treatment of diabetic ketoacidosis. REZVOGLAR™ is a long-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. ( 1 ) Limitations of Use : Not recommended for the treatment of diabetic ketoacidosis. ( 1 )